Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

5.6.2

Moderate Reaction

Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 5, Blood and Haematology.

Signs and Symptoms

  • Anxiety, pruritus, palpitations, mild dyspnea, headache, rigors, fever, tachycardia

Possible causes:

  • Hypersensitivity (moderate to severe)
  • Febrile non-haemolytic transfusion reaction
  • Contamination with pyrogens and / or bacteria.

Treatment

  • Seek help immediately from the anaesthetic, emergency team or whoever is available and skilled to assist
  • Stop the transfusion
  • Replace the infusion set and keep IV line open with normal saline.
  • Administer antihistamine IM/IV or PO
  • Chlorpheniramine 0.1 mg/kg IM or IV for children; 10mg IM/IV for adult or Chlorpheniramine 4mg PO.
  • Promethazine 6.25-12.5mg for children aged 5-12 years and Promethazine 25mg for adults.
  • Give oral or rectal antipyretic (e.g., Paracetamol 10 mg/kg or 0.5g - 1g in adults.

DON’T give Aspirin.

  • Give IV corticosteroids (e.g., Hydrocortisone 200mg IV stat) and bronchodilators (e.g. salbutamol 5mg nebulization or salbutamol inhaler 2 puffs (if nebule not available) STAT or Aminophylline 100mg STAT) if there are anaphylactoid features (e.g. bronchospasm, stridor).
  • If there is clinical improvement, restart transfusion slowly with new blood unit and observe carefully. May need to redo group and crossmatch
  • If no clinical improvement within 15 minutes or if signs and symptoms worsen, treat as Category 3.

Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.